Comparative effect of aspirin and clopidogrel on arterial function in CHF

International Journal of Cardiology

Volumn 106, Issue 1, 2006, Pages 61-66

  Meune, Christophe ^a   Mahé, Isabelle ^b   Solal, Alain Cohen ^c   Lévy, Bernard I ^b   Duboc, Denis ^a   Simoneau, Guy ^b   Champion, Karine ^b   Mourad, Jean Jacques ^d   Weber, Simon ^a   Bergmann, Jean François ^b  

^a Rene Descartes University ^*  (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c BEAUJON HOSPITAL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Angiotensin converting enzyme inhibitors; Aspirin; Clopidogrel; Heart failure

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART EJECTION FRACTION; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TONOMETRY; WAVEFORM;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; TICLOPIDINE;

EID: 28444460400     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.12.059     Document Type: Article

References (37)

1. D.L. Mann Mechanisms and models in heart failure Circulation 100 1999 999 1008
2. The Collaborative Group on ACE Inhibitors Trial Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure JAMA 273 1995 1450 1456
3. W.J. Remme, and K. Swedberg Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology Eur Heart J 22 2001 1527 1560
4. J.V. Gainer, J.D. Morrow, A. Loveland, D.J. King, and N.J. Brown Effect of bradykinin-receptor blockade on the response to angiotensin-converting enzyme inhibitor in normotensive and hypertensive subjects N Engl J Med 339 1998 1285 1292
5. F.N. Witherow, A. Helmy, D.J. Webb, K.A.A. Fox, and D.E. Newby Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure Circulation 104 2001 2177 2181
6. R.D. Minshall, F. Tan, F. Nakamura, S.F. Rabito, R.P. Becker, and B. Marcic Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells Circ Res 81 1997 848 856
7. G. Bönner The role of kinins in the antihypertensive and cardioprotective effects of ACE inhibitors Drugs 54 suppl 5 1997 23 30
8. J.N. Townend, J. Doran, C. Lote, and M.K. Davies Peripheral hemodynamics effects of inhibition of prostaglandin synthesis in congestive heart failure and interaction with captopril Br Heart J 73 1995 734 741
9. C. Meune, J.J. Mourad, J.F. Bergmann, and C. Spaulding Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance J Renin Angiotensin Aldosterone Syst 4 2003 149 154
10. J.G. Cleland, J. John, and T. Houghton Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure? Curr Opin Nephrol Hypertens 10 2001 625 631
11. V.J. Dzau, M. Packer, L.S. Lilly, S.L. Schwartz, N.K. Hollenberg, and G.H. Williams Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia N Engl J Med 310 1984 347 352
12. D. Hall The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not J Am Coll Cardiol 35 2000 1808 1812
13. A.I. Malinin, C.M. O'Connor, A.I. Dzhanashvili, D.C. Sane, and V.L. Sebruany Platelet activation in patients with congestive heart failure: do we have enough evidence to consider clopidogrel? Am Heart J 145 2003 397 403
14. M. Echemann, F. Alla, S. Briançon, Y. Juillière, J.M. Virion, and P.M. Mertès Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study) Eur J Heart Fail 4 2002 647 654
15. V.L. Serebruany, A.I. Malinin, S.D. Jerome, D.R. Lowry, A.W. Morgan, and D.C. Sane Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure. The plavix use for treatment of congestive heart failure (PLUTO-CHF) trial Am Heart J 146 2003 713 720
16. C. Spaulding, B. Charbonnier, A. Cohen-Solal, Y. Juillière, E.P. Kromer, and K. Benhamda Acute haemodynamic interaction of aspirin and ticlodipine with enalapril Circulation 98 1998 757 765
17. V. Aumégeat, N. Lamblin, P. de Groote, E.P. Mc Fadden, A. Miliaire, and C. Bauters Aspirin does not adversely affect survival in patients with stable congestive heart failure treated angiotensin-converting enzyme inhibitors Chest 124 2003 1250 1258
18. K.K. Teo for the ACE inhibitor collaborative group Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: a systematic review Lancet 360 2002 1037 1043
19. B.M. Massie, W.F. Krol, S.E. Ammon, P.W. Armstrong, J.G. Cleland, and J.F. Collins The warfarin and antiplatelet therapy in heart failure trial (WATCH): rationale, design, and baseline patients characteristics J Card Fail 10 2004 101 120
20. M. Guazzi, R. Brambilla, G. Reina, G. Tumminello, and M.D. Guazzi Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure: dose-related adverse effect of aspirin Arch Intern Med 163 2003 1574 1579
21. CAPRIE steering committee A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
22. The Clopidogrel in Unstable Angina to prevent Recurrent Events Trial Investigators (CURE) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
23. R. Kelly, C. Hayward, J. Ganis, J. Daley, A. Avolio, and M. O'rourke Noninvasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry J Vasc Med Biol 1 1989 142 149
24. C. Meune, I. Mahé, J.J. Mourad, A. Cohen-Solal, B. Levy, and J.P. Kevorkian Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect Eur J Heart Fail 5 2003 271 279
25. J. Blacher, A.P. Guerin, B. Pannier, S.J. Marchais, M.E. Safar, and G.M. London Impact of aortic stiffness on survival in end-stage renal disease Circulation 99 1999 2434 2439
26. C.H. Chen, C.T. Ting, A. Nussbacher, E. Nevo, D.A. Kass, and P. Park Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure Hypertension 27 1996 168 175
27. G.M. London, J. Blacher, B. Pannier, A.P. Guerin, S.J. Marchais, and M.E. Safar Arterial wave reflections and survival in end-stage renal failure Hypertension 38 2001 434 438
28. M.F. O'Rourke Mechanical principles. Arterial stiffness and wave reflection Pathol Biol 47 1999 623 633
29. A.P. Davie, M.P. Love, and J.J.V. McMurray Even low-dose aspirin inhibits arachidonic acid-induced vasodilatation in heart failure Clin Pharmacol Ther 67 2000 530 537
30. S. Galatius, H. Wroblewski, and J. Kastrup Does aspirin treatment influence vascular resistance and fluid filtration in patients with congestive heart failure Heart 81 1999 330
31. U.P. Jorde, P.V. Ennezat, J. Lisker, V. Suryadevara, J. Infeld, and S. Cukon Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure Circulation 101 2000 844 846
32. B. Pitt, P.A. Poole-Wilson, R. Segal, F.A. Martinez, K. Dickstein, and A.J. Camm Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial; the losartan heart failure survival study ELITE II Lancet 355 2000 1582 1587
33. J.G. Cleland, I. Findlay, S. Jafri, G. Sutton, R. Falk, and C. Bulpitt The warfarin/aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure Am Heart J 148 2004 157 164
34. R.J. Peters, S.R. Mehta, K.A. Fox, F. Zhao, B.S. Lewis, S.L. Kopecky Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the clopidogrel in unstable angina to prevent recurrent events (CURE) study Circulation 108 2003 1682 1687
35. E. Lim, Z. Ali, A. Ali, T. Routledge, L. Edmonds, and D.G. Altman Indirect comparison meta-analysis of aspirin therapy after surgery Br Med J 327 2003 1309 1314
36. T. Weber, B. Eber, and J. Auer Aspirin, ACE inhibitors and arterial stiffness Eur J Heart Fail 6 2004 117 118
37. S. Kindvaster, K. Leclerc, and J. Ward Effects of coadministration of aspirin or clopidogrel on exercise testing in patients with heart failure receiving angiotensin-converting enzyme inhibitors Am J Cardiol 91 2003 1350 1352